I think that the dividend stock most likely to double in 2021 is… Innovative Industrial Properties (NYSE: IIPR) (FRA: 1IK). One such stock especially stands out, in my opinion. They pay attractive dividends and deliver impressive growth at the same time. There are some dividend stocks, however, that are more hares than tortoises. Given enough time, dividend stocks can make investors a lot of money. IIPR More Than Doubled So Far This Year and is in a Strong Position for a Repeat Performanceĭividend stocks aren’t generally known for generating tremendous gains over short periods. Here’s the Dividend Pot Stock Most Likely to Double in 2021 * Yahoo Finance readers, please click here to view the full article.ġ0. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock News Stories for the Week of December 21st – 27th, 2020. Tickets for this first-of-its-kind gathering are still available here.Welcome to the Cannabis Countdown. To hear more about the important and fascinating scientific advances and meet face-to-face with some of this nascent industry’s professionals & market leaders, join us at the Benzinga Psychedelics Capital Conference on Apat the Fontainebleau Miami Beach where we are bringing together leaders of the largest publicly-traded Psychedelics companies with investors from across North America. But, who is the real Kevin O'Leary? Read the full story… Wonderful, the Canadian investor of Irish heritage is well known in the finance space and as a TV personality. Whether you're into finances or just a fan of Shark Tank, chances are you know who Kevin O’Leary is. Read the full story… 'Psychedelics Companies Are Onto Something Extraordinary,' Says Kevin O'Leary: Meet Our Keynote Speakers (OTC:IWINF), an herbal supplement formulator and leader in the nutrition industry at the forefront of the "psychedelics renaissance." Klee Irwin serves as CEO and chairman of Irwin Naturals and director of Quantum Gravity Research, a non-profit research institute he founded in 2009. Meet the person behind Irwin Naturals Inc. Klee Irwin Of Irwin Naturals At The Forefront Of 'Psychedelics Renaissance': Meet Our Keynote Speakers (OTC:ALID) has successfully filed for a full patent regarding “Dosing regimes of pharmaceutical and nutraceutical mushroom and cannabis compositions and their use to treat CNS disorders and improve mental health." Read the full story… Files Full Psilocybin Patent For Psilonex To Treat Central Nervous System DisordersĪllied Corp. (OTC:NVMDF) has been selected by Mind Medicine, Inc. (NASDAQ:MNMD) to host a Phase IIb randomized clinical trial investigating lysergic acid diethylamide (LSD) for generalized anxiety disorder in adults. Read the full story… Novamind To Host MindMed Phase IIb Trial For LSD Based Drug For Anxiety Treatment The bill also proposes relying on current cannabis regulatory systems to track psychedelic mushrooms, reported Marijuana Moment. Read the full story… Washington State Legislature Proposes $200K To Fund Psilocybin ResearchĪ new budget bill with a proposal to earmark $200,000 for researching the possibility of legalizing psilocybin services in Washington State was filed by the State legislature on Thursday. (OTC:WSNAF) have received a full written response from the Food and Drug Administration regarding their pre-investigational new drug meeting for the novel therapy and proprietary protocol of SANA-013 for the treatment of traumatic brain injury-related major depressive disorder. Read the full story… Wesana Health One Step Closer To Clinical Trials Of Psilocybin And CBD Based Treatment Of Brain Injury Related MDD (OTC:MCURF), a mental health and wellness company working in the psychedelics sector, announced that a special committee its board of directors concluded a review process and has determined that the capital required to continue the Company's business plan is unlikely to be found under the current and foreseeable market conditions. Mind Cure Health Is Shutting Down All Operations, Citing Lack Of Funds To Move Forward
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |